2367 — Giant Biogene Holding Co Cashflow Statement
0.000.00%
Last trade - 00:00- HK$81.18bn
- HK$74.96bn
- CNY5.54bn
- 70
- 11
- 98
- 66
Annual cashflow statement for Giant Biogene Holding Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | — |
| Source: | PROSPECTUS | PROSPECTUS | ARS | ARS | |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | fx Preliminary |
| Net Income/Starting Line | 973 | 973 | 1,178 | 1,745 | — |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | -165 | -28.3 | 31.7 | -52.5 | — |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 4.64 | -275 | -305 | -79.3 | — |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 834 | 692 | 932 | 1,647 | — |
| Capital Expenditures | -76.3 | -111 | -153 | -228 | — |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -445 | 1,674 | -705 | -299 | — |
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -521 | 1,563 | -859 | -527 | — |
| Financing Cash Flow Items | -17.5 | -2,619 | -379 | -3.54 | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -17.5 | 4,476 | -5,790 | 51.8 | — |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 295 | 6,735 | -5,772 | 1,173 | — |